These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5061304)

  • 1. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat.
    Weisburger JH; Yamamoto RS; Williams GM; Grantham PH; Matsushima T; Weisburger EK
    Cancer Res; 1972 Mar; 32(3):491-500. PubMed ID: 5061304
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide.
    Yamamoto RS; Williams GM; Richardson HL; Weisburger EK; Weisburger JH
    Cancer Res; 1973 Mar; 33(3):454-7. PubMed ID: 4347712
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
    Irving CC; Peeler TC; Veazey RA; Wiseman R
    Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
    [No Abstract]   [Full Text] [Related]  

  • 4. N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver.
    DeBaun JR; Miller EC; Miller JA
    Cancer Res; 1970 Mar; 30(3):577-95. PubMed ID: 5425283
    [No Abstract]   [Full Text] [Related]  

  • 5. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats.
    Ulland BM; Weisburger JH; Yamamoto RS; Weisburger EK
    Food Cosmet Toxicol; 1973 Apr; 11(2):199-207. PubMed ID: 4352030
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex differences in cell proliferation and N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration.
    Jackson CD; Irving CC
    Cancer Res; 1972 Jul; 32(7):1590-4. PubMed ID: 5030584
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased activity of polynucleotide ligase from rat hepatoma induced by N-2-fluorenylacetamide.
    Tsukada K; Hokari S; Hayasaki N; Ito N
    Cancer Res; 1972 May; 32(5):886-8. PubMed ID: 4336027
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of rat liver ribonucleic acid polymerase by the carcinogen N-hydroxy-2-fluorenylacetamide.
    Zieve FJ
    J Biol Chem; 1972 Sep; 247(18):5987-95. PubMed ID: 5057094
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of acetanilide and p-hydroxyacetanilide on the carcinogenicity of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in mice, hamsters, and female rats.
    Weisburger JH; Weisburger EK; Madison RM; Wenk ML; Klein DS
    J Natl Cancer Inst; 1973 Jul; 51(1):235-40. PubMed ID: 4720874
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 11. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF; Sell S
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract]   [Full Text] [Related]  

  • 12. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
    Matsushima T; Weisburger JH
    Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H; Verney E
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic effect of testosterone on rat liver tumor induction by N-2-fluorenylacetamide.
    Toh YC
    J Natl Cancer Inst; 1972 Jan; 48(1):113-8. PubMed ID: 4652367
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on chromatin. II. Effects of carcinogens and hormones on rat liver chromatin.
    Sporn MB; Dingman CW
    Cancer Res; 1966 Dec; 26(12):2488-95. PubMed ID: 4959456
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T; Sugano H
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blastomogenesis in rats in the presence of the combined action of N-2-fluorenylacetamide and N-nitrosodimethylamine].
    Likhachev AIa
    Vopr Onkol; 1969; 15(9):65-9. PubMed ID: 5354750
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hypo- and hyperglycemic sulfonamides on the cancerous process of rat liver by 2-acetylaminofluorene].
    Lacassagne A; Hurst L
    Bull Cancer; 1969; 56(4):397-410. PubMed ID: 4928249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.